Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.
about
Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@en
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@nl
type
label
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@en
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@nl
prefLabel
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@en
Survival Outcomes of Concurren ...... ion-Resistant Prostate Cancer.
@nl
P2860
P50
P1476
Survival Outcomes of Concurren ...... tion-Resistant Prostate Cancer
@en
P2093
Ho Seong Jang
P2860
P304
P356
10.3349/YMJ.2016.57.5.1070
P577
2016-09-01T00:00:00Z